feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Cooling Collar Targets Traumatic Brain Injury Recovery

Cooling Collar Targets Traumatic Brain Injury Recovery

2 Feb

•

Summary

  • A new study will test a cooling collar for traumatic brain injury recovery.
  • The device offers targeted brain cooling, unlike whole-body methods.
  • This is the world's first in-human study of this pioneering medical device.
Cooling Collar Targets Traumatic Brain Injury Recovery

A new study commencing this month at Addenbrooke's Hospital will investigate the efficacy of a targeted cooling collar in improving recovery for patients with traumatic brain injuries (TBIs).

This initiative is the world's first in-human trial to assess the pioneering medical device, named CB240 Aurora, which is designed for selective temperature control around the neck to lower brain temperature.

Unlike conventional whole-body cooling methods that can cause systemic side effects such as immune suppression and chest infections, this portable collar aims for a more focused approach.

The SELETHERM 2 study will enroll twenty patients with severe TBIs over twelve months, with half receiving the selective brain cooling for the first 72 hours.

Researchers hope that by minimizing systemic effects, the neuroprotective benefits of hypothermia, previously obscured by side effects, can be realized, potentially improving long-term quality of life for survivors.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
The CB240 Aurora is a selective temperature-control device applied around the neck, designed to lower brain temperature in a targeted way to aid recovery from traumatic brain injuries.
Selective brain cooling aims to mitigate systemic side effects associated with conventional whole-body cooling strategies, which can complicate patient recovery.
The SELETHERM 2 study is expected to enroll twenty patients with severe traumatic brain injury over a 12-month period.

Read more news on

Healthside-arrow
trending

Hetmyer's visa delays World Cup

trending

Ola Uber Rapido strike

trending

West Indies face Scotland again

trending

Pakistan beats Netherlands in T20

trending

Mark Watt confident facing Windies

trending

T20 World Cup 2026

trending

Van Beek: Beat India, Pakistan

trending

T20 World Cup 2026 details

trending

Jasdeep Singh's dream wickets

You may also like

Hospital Program Bridges Hospital to Home Care Gap

4 Feb • 19 reads

Addenbrooke's Neuroscience Unit Under Urgent Review

31 Jan • 36 reads

article image

Gas Leak Ignites Chawl Fire: One Critical

21 Dec, 2025 • 226 reads

article image

New £6.5m Robotic Theatre Promises Quicker Recovery

22 Dec, 2025 • 243 reads

article image

Miracle Micro Preemie Beats Odds at 480 Grams

10 Dec, 2025 • 192 reads

article image